Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology

References

• Britt WA, Alford CA. Cytomegalovirus. In: Fields BN, Roizman B, Knipe DM, Melnick JL, Howley PM, Chanock RM, et al., eds. Fields Virology. Philiadelphia: Lippincott-Raven Publishers, 1996:2493-523.
   Google Scholar
• Pass RF. Cytomegalovirus. In: Knipe DM, Howley PM, eds. Fields Virology. Philadephia: Lippincott Williams & Wilkins, 2001:2675-706.
   Google Scholar
• Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer?. J Intern Med 2006; 259:219 - 46; http://dx.doi.org/10.1111/j.1365-2796.2006.01618.x; PMID: 16476101
   PubMed Web of Science ®Google Scholar
• Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 1999; 5:1039 - 43; http://dx.doi.org/10.1038/12478; PMID: 10470081
   PubMed Web of Science ®Google Scholar
• Odeberg J, Plachter B, Brandén L, Söderberg-Nauclér C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 2003; 101:4870 - 7; http://dx.doi.org/10.1182/blood-2002-05-1504; PMID: 12609847
   PubMed Web of Science ®Google Scholar
• Hegde NR, Tomazin RA, Wisner TW, Dunn C, Boname JM, Lewinsohn DM, et al. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. J Virol 2002; 76:10929 - 41; http://dx.doi.org/10.1128/JVI.76.21.10929-10941.2002; PMID: 12368336
   PubMed Web of Science ®Google Scholar
• Loenen WA, Bruggeman CA, Wiertz EJ. Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin Immunol 2001; 13:41 - 9; http://dx.doi.org/10.1006/smim.2001.0294; PMID: 11289798
   PubMed Web of Science ®Google Scholar
• Noriega V, Redmann V, Gardner T, Tortorella D. Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 2012; http://dx.doi.org/10.1007/s12026-012-8304-8; PMID: 22454101
   PubMed Web of Science ®Google Scholar
• Kim S, Lee S, Shin J, Kim Y, Evnouchidou I, Kim D, et al. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 2011; 12:984 - 91; http://dx.doi.org/10.1038/ni.2097; PMID: 21892175
   PubMed Web of Science ®Google Scholar
• Hansen SG, Powers CJ, Richards R, Ventura AB, Ford JC, Siess D, et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010; 328:102 - 6; http://dx.doi.org/10.1126/science.1185350; PMID: 20360110
   PubMed Web of Science ®Google Scholar
• Wilkinson GW, Tomasec P, Stanton RJ, Armstrong M, Prod’homme V, Aicheler R, et al. Modulation of natural killer cells by human cytomegalovirus. J Clin Virol 2008; 41:206 - 12; http://dx.doi.org/10.1016/j.jcv.2007.10.027; PMID: 18069056
   PubMed Web of Science ®Google Scholar
• Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331:269 - 72; http://dx.doi.org/10.1038/331269a0; PMID: 2827039
   PubMed Web of Science ®Google Scholar
• Odeberg J, Cerboni C, Browne H, Kärre K, Möller E, Carbone E, et al. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol 2002; 55:149 - 61; http://dx.doi.org/10.1046/j.1365-3083.2002.01025.x; PMID: 11896931
   PubMed Web of Science ®Google Scholar
• Belz GT, Nutt SL. Transcriptional programming of the dendritic cell network. Nat Rev Immunol 2012; 12:101 - 13; http://dx.doi.org/10.1038/nri3149; PMID: 22273772
   PubMed Web of Science ®Google Scholar
• Liu K, Nussenzweig MC. Origin and development of dendritic cells. Immunol Rev 2010; 234:45 - 54; http://dx.doi.org/10.1111/j.0105-2896.2009.00879.x; PMID: 20193011
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109 - 18; http://dx.doi.org/10.1084/jem.179.4.1109; PMID: 8145033
   PubMed Web of Science ®Google Scholar
• Ross MJ, Auger JA. The biology of the macrophage. In: Burke B, Lewis CE, eds. The Macrophage. Oxford: Oxford University Press, 2002:1-72.
   Google Scholar
• Söderberg-Nauclér C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA. Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 2001; 75:7543 - 54; http://dx.doi.org/10.1128/JVI.75.16.7543-7554.2001; PMID: 11462026
   PubMed Web of Science ®Google Scholar
• Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101:4560 - 5; http://dx.doi.org/10.1073/pnas.0400983101; PMID: 15070757
   PubMed Web of Science ®Google Scholar
• Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010; 234:142 - 62; http://dx.doi.org/10.1111/j.0105-2896.2009.00881.x; PMID: 20193017
   PubMed Web of Science ®Google Scholar
• Villadangos JA, Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008; 29:352 - 61; http://dx.doi.org/10.1016/j.immuni.2008.09.002; PMID: 18799143
   PubMed Web of Science ®Google Scholar
• Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8:594 - 606; http://dx.doi.org/10.1038/nri2358; PMID: 18641647
   PubMed Web of Science ®Google Scholar
• Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 2004; 103:1433 - 7; http://dx.doi.org/10.1182/blood-2003-08-2674; PMID: 14563635
   PubMed Web of Science ®Google Scholar
• Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198:513 - 20; http://dx.doi.org/10.1084/jem.20030162; PMID: 12900525
   PubMed Web of Science ®Google Scholar
• Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21:107 - 19; http://dx.doi.org/10.1016/j.immuni.2004.06.007; PMID: 15345224
   PubMed Web of Science ®Google Scholar
• Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP, et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol 2007; 179:7767 - 76; PMID: 18025223
   PubMed Web of Science ®Google Scholar
• Gerna G, Zipeto D, Percivalle E, Parea M, Revello MG, Maccario R, et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166:1236 - 44; http://dx.doi.org/10.1093/infdis/166.6.1236; PMID: 1331248
   PubMed Web of Science ®Google Scholar
• Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991; 72:2059 - 64; http://dx.doi.org/10.1099/0022-1317-72-9-2059; PMID: 1654370
   PubMed Web of Science ®Google Scholar
• Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991; 65:6581 - 8; PMID: 1658363
   PubMed Web of Science ®Google Scholar
• Taylor-Wiedeman J, Sissons P, Sinclair J. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J Virol 1994; 68:1597 - 604; PMID: 8107221
   PubMed Web of Science ®Google Scholar
• Minton EJ, Tysoe C, Sinclair JH, Sissons JG. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol 1994; 68:4017 - 21; PMID: 8189535
   PubMed Web of Science ®Google Scholar
• Einhorn L, Ost A. Cytomegalovirus infection of human blood cells. J Infect Dis 1984; 149:207 - 14; http://dx.doi.org/10.1093/infdis/149.2.207; PMID: 6321607
   PubMed Web of Science ®Google Scholar
• Gnann JW Jr., Ahlmén J, Svalander C, Olding L, Oldstone MB, Nelson JA. Inflammatory cells in transplanted kidneys are infected by human cytomegalovirus. Am J Pathol 1988; 132:239 - 48; PMID: 2840830
   PubMed Web of Science ®Google Scholar
• Fish KN, Depto AS, Moses AV, Britt W, Nelson JA. Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol 1995; 69:3737 - 43; PMID: 7745721
   PubMed Web of Science ®Google Scholar
• Söderberg-Nauclér C, Fish KN, Nelson JA. Growth of human cytomegalovirus in primary macrophages. Methods 1998; 16:126 - 38; http://dx.doi.org/10.1006/meth.1998.0650; PMID: 9774522
   PubMed Web of Science ®Google Scholar
• Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, et al. Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996; 88:4526 - 33; PMID: 8977244
   PubMed Web of Science ®Google Scholar
• Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol 1996; 77:3099 - 102; http://dx.doi.org/10.1099/0022-1317-77-12-3099; PMID: 9000102
   PubMed Web of Science ®Google Scholar
• Movassagh M, Gozlan J, Senechal B, Baillou C, Petit JC, Lemoine FM. Direct infection of CD34+ progenitor cells by human cytomegalovirus: evidence for inhibition of hematopoiesis and viral replication. Blood 1996; 88:1277 - 83; PMID: 8695845
   PubMed Web of Science ®Google Scholar
• Khaiboullina SF, Maciejewski JP, Crapnell K, Spallone PA, Dean Stock A, Pari GS, et al. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 2004; 126:410 - 7; http://dx.doi.org/10.1111/j.1365-2141.2004.05056.x; PMID: 15257715
   PubMed Web of Science ®Google Scholar
• Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005; 102:4140 - 5; http://dx.doi.org/10.1073/pnas.0408994102; PMID: 15738399
   PubMed Web of Science ®Google Scholar
• Söderberg-Nauclér C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91:119 - 26; http://dx.doi.org/10.1016/S0092-8674(01)80014-3; PMID: 9335340
   PubMed Web of Science ®Google Scholar
• Söderberg-Nauclér C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997; 100:3154 - 63; http://dx.doi.org/10.1172/JCI119871; PMID: 9399963
   PubMed Web of Science ®Google Scholar
• Reeves MB, Compton T. Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J Virol 2011; 85:12750 - 8; http://dx.doi.org/10.1128/JVI.05878-11; PMID: 21937636
   PubMed Web of Science ®Google Scholar
• Hargett D, Shenk TE. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc Natl Acad Sci USA 2010; 107:20039 - 44; http://dx.doi.org/10.1073/pnas.1014509107; PMID: 21041645
   PubMed Web of Science ®Google Scholar
• Döcke WD, Prösch S, Fietze E, Kimel V, Zuckermann H, Klug C, et al. Cytomegalovirus reactivation and tumour necrosis factor. Lancet 1994; 343:268 - 9; http://dx.doi.org/10.1016/S0140-6736(94)91116-9; PMID: 7905100
   PubMed Web of Science ®Google Scholar
• Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis 1998; 26:1076 - 82; http://dx.doi.org/10.1086/520307; PMID: 9597229
   PubMed Web of Science ®Google Scholar
• Asadullah K, Prösch S, Audring H, Büttnerova I, Volk HD, Sterry W, et al. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression. Br J Dermatol 1999; 141:94 - 102; http://dx.doi.org/10.1046/j.1365-2133.1999.02926.x; PMID: 10417521
   PubMed Web of Science ®Google Scholar
• Gredmark S, Söderberg-Nauclér C. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J Virol 2003; 77:10943 - 56; http://dx.doi.org/10.1128/JVI.77.20.10943-10956.2003; PMID: 14512544
   PubMed Web of Science ®Google Scholar
• Carlier J, Martin H, Mariamé B, Rauwel B, Mengelle C, Weclawiak H, et al. Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells. Blood 2011; 118:6783 - 92; http://dx.doi.org/10.1182/blood-2011-02-337956; PMID: 22031867
   PubMed Web of Science ®Google Scholar
• Gredmark S, Tilburgs T, Söderberg-Nauclér C. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol 2004; 78:10378 - 89; http://dx.doi.org/10.1128/JVI.78.19.10378-10389.2004; PMID: 15367604
   PubMed Web of Science ®Google Scholar
• Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Möller E. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67:6576 - 85; PMID: 8105105
   PubMed Web of Science ®Google Scholar
• Gredmark S, Britt WB, Xie X, Lindbom L, Söderberg-Nauclér C. Human cytomegalovirus induces inhibition of macrophage differentiation by binding to human aminopeptidase N/CD13. J Immunol 2004; 173:4897 - 907; PMID: 15470031
   PubMed Web of Science ®Google Scholar
• Mutimer D, Mirza D, Shaw J, O’Donnell K, Elias E. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients. Transplantation 1997; 63:1411 - 5; http://dx.doi.org/10.1097/00007890-199705270-00007; PMID: 9175802
   PubMed Web of Science ®Google Scholar
• van den Berg AP, Klompmaker IJ, Haagsma EB, Peeters PM, Meerman L, Verwer R, et al. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin Transplant 1996; 10:224 - 31; PMID: 8664524
   PubMed Web of Science ®Google Scholar
• Paya CV, Wiesner RH, Hermans PE, Larson-Keller JJ, Ilstrup DM, Krom RA, et al. Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol 1993; 18:185 - 95; http://dx.doi.org/10.1016/S0168-8278(05)80245-4; PMID: 8409334
   PubMed Web of Science ®Google Scholar
• Riegler S, Hebart H, Einsele H, Brossart P, Jahn G, Sinzger C. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol 2000; 81:393 - 9; PMID: 10644837
   PubMed Web of Science ®Google Scholar
• Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol 2008; 325:63 - 83; http://dx.doi.org/10.1007/978-3-540-77349-8_4; PMID: 18637500
   PubMed Web of Science ®Google Scholar
• Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, Messerle M, et al. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 2008; 89:359 - 68; http://dx.doi.org/10.1099/vir.0.83286-0; PMID: 18198366
   PubMed Web of Science ®Google Scholar
• Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 2005; 86:275 - 84; http://dx.doi.org/10.1099/vir.0.80474-0; PMID: 15659746
   PubMed Web of Science ®Google Scholar
• Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, Sarasini A, et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004; 78:10023 - 33; http://dx.doi.org/10.1128/JVI.78.18.10023-10033.2004; PMID: 15331735
   PubMed Web of Science ®Google Scholar
• Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, Houlès C, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002; 17:653 - 64; http://dx.doi.org/10.1016/S1074-7613(02)00447-8; PMID: 12433371
   PubMed Web of Science ®Google Scholar
• Plazolles N, Humbert JM, Vachot L, Verrier B, Hocke C, Halary F. Pivotal advance: The promotion of soluble DC-SIGN release by inflammatory signals and its enhancement of cytomegalovirus-mediated cis-infection of myeloid dendritic cells. J Leukoc Biol 2011; 89:329 - 42; http://dx.doi.org/10.1189/jlb.0710386; PMID: 20940323
   PubMed Web of Science ®Google Scholar
• Haspot F, Lavault A, Sinzger C, Laib Sampaio K, Stierhof YD, Pilet P, et al. Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner. PLoS One 2012; 7:e34795; http://dx.doi.org/10.1371/journal.pone.0034795; PMID: 22496863
   PubMedGoogle Scholar
• Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schönrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001; 15:997 - 1009; http://dx.doi.org/10.1016/S1074-7613(01)00239-4; PMID: 11754820
   PubMed Web of Science ®Google Scholar
• Beck K, Meyer-König U, Weidmann M, Nern C, Hufert FT. Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur J Immunol 2003; 33:1528 - 38; http://dx.doi.org/10.1002/eji.200323612; PMID: 12778470
   PubMed Web of Science ®Google Scholar
• Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002; 99:2913 - 21; http://dx.doi.org/10.1182/blood.V99.8.2913; PMID: 11929782
   PubMed Web of Science ®Google Scholar
• Mezger M, Bonin M, Kessler T, Gebhardt F, Einsele H, Loeffler J. Toll-like receptor 3 has no critical role during early immune response of human monocyte-derived dendritic cells after infection with the human cytomegalovirus strain TB40E. Viral Immunol 2009; 22:343 - 51; http://dx.doi.org/10.1089/vim.2009.0011; PMID: 19951172
   PubMed Web of Science ®Google Scholar
• Sénéchal B, Boruchov AM, Reagan JL, Hart DN, Young JW. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 2004; 103:4207 - 15; http://dx.doi.org/10.1182/blood-2003-12-4350; PMID: 14962896
   PubMed Web of Science ®Google Scholar
• Wagner CS, Walther-Jallow L, Buentke E, Ljunggren HG, Achour A, Chambers BJ. Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells. J Leukoc Biol 2008; 83:56 - 63; http://dx.doi.org/10.1189/jlb.0307181; PMID: 17898320
   PubMed Web of Science ®Google Scholar
• Moutaftsi M, Brennan P, Spector SA, Tabi Z. Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J Virol 2004; 78:3046 - 54; http://dx.doi.org/10.1128/JVI.78.6.3046-3054.2004; PMID: 14990723
   PubMed Web of Science ®Google Scholar
• Varani S, Frascaroli G, Homman-Loudiyi M, Feld S, Landini MP, Söderberg-Nauclér C. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J Leukoc Biol 2005; 77:219 - 28; http://dx.doi.org/10.1189/jlb.0504301; PMID: 15522919
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci USA 2000; 97:1695 - 700; http://dx.doi.org/10.1073/pnas.97.4.1695; PMID: 10677520
   PubMed Web of Science ®Google Scholar
• Jenkins C, Abendroth A, Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 2004; 78:1440 - 7; http://dx.doi.org/10.1128/JVI.78.3.1440-1447.2004; PMID: 14722299
   PubMed Web of Science ®Google Scholar
• Jenkins C, Garcia W, Godwin MJ, Spencer JV, Stern JL, Abendroth A, et al. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol 2008; 82:3736 - 50; http://dx.doi.org/10.1128/JVI.02173-07; PMID: 18216121
   PubMed Web of Science ®Google Scholar
• Avdic S, Cao JZ, Cheung AK, Abendroth A, Slobedman B. Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation. J Virol 2011; 85:7465 - 71; http://dx.doi.org/10.1128/JVI.00088-11; PMID: 21593144
   PubMed Web of Science ®Google Scholar
• Chang WL, Baumgarth N, Yu D, Barry PA. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol 2004; 78:8720 - 31; http://dx.doi.org/10.1128/JVI.78.16.8720-8731.2004; PMID: 15280480
   PubMed Web of Science ®Google Scholar
• Raftery MJ, Wieland D, Gronewald S, Kraus AA, Giese T, Schönrich G. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol 2004; 173:3383 - 91; PMID: 15322202
   PubMed Web of Science ®Google Scholar
• Raftery MJ, Hitzler M, Winau F, Giese T, Plachter B, Kaufmann SH, et al. Inhibition of CD1 antigen presentation by human cytomegalovirus. J Virol 2008; 82:4308 - 19; http://dx.doi.org/10.1128/JVI.01447-07; PMID: 18287231
   PubMed Web of Science ®Google Scholar
• Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol 2003; 77:7563 - 74; http://dx.doi.org/10.1128/JVI.77.13.7563-7574.2003; PMID: 12805456
   PubMed Web of Science ®Google Scholar
• Lee AW, Hertel L, Louie RK, Burster T, Lacaille V, Pashine A, et al. Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol 2006; 177:3960 - 71; PMID: 16951359
   PubMed Web of Science ®Google Scholar
• Lee AW, Wang N, Hornell TM, Harding JJ, Deshpande C, Hertel L, et al. Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels. Mol Immunol 2011; 48:1160 - 7; http://dx.doi.org/10.1016/j.molimm.2011.02.010; PMID: 21458073
   PubMed Web of Science ®Google Scholar
• Kvale EO, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, et al. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood 2006; 107:2022 - 9; http://dx.doi.org/10.1182/blood-2005-05-2016; PMID: 16269620
   PubMed Web of Science ®Google Scholar
• Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 2009; 390:330 - 7; http://dx.doi.org/10.1016/j.virol.2009.05.013; PMID: 19524994
   PubMed Web of Science ®Google Scholar
• Cederarv M, Söderberg-Nauclér C, Odeberg J. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity. Immunobiology 2009; 214:331 - 41; http://dx.doi.org/10.1016/j.imbio.2008.10.009; PMID: 19152985
   PubMed Web of Science ®Google Scholar
• Schneider K, Meyer-Koenig U, Hufert FT. Human cytomegalovirus impairs the function of plasmacytoid dendritic cells in lymphoid organs. PLoS One 2008; 3:e3482; http://dx.doi.org/10.1371/journal.pone.0003482; PMID: 18941519
   PubMedGoogle Scholar
• Kurts C, Robinson BW, Knolle PA. Cross-priming in health and disease. Nat Rev Immunol 2010; 10:403 - 14; http://dx.doi.org/10.1038/nri2780; PMID: 20498667
   PubMed Web of Science ®Google Scholar
• Arrode G, Boccaccio C, Lulé J, Allart S, Moinard N, Abastado JP, et al. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J Virol 2000; 74:10018 - 24; http://dx.doi.org/10.1128/JVI.74.21.10018-10024.2000; PMID: 11024130
   PubMed Web of Science ®Google Scholar
• Tabi Z, Moutaftsi M, Borysiewicz LK. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J Immunol 2001; 166:5695 - 703; PMID: 11313411
   PubMed Web of Science ®Google Scholar
• Mandron M, Martin H, Bonjean B, Lulé J, Tartour E, Davrinche C. Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells. J Gen Virol 2008; 89:78 - 86; http://dx.doi.org/10.1099/vir.0.83278-0; PMID: 18089731
   PubMed Web of Science ®Google Scholar
• Magri G, Muntasell A, Romo N, Sáez-Borderías A, Pende D, Geraghty DE, et al. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 2011; 117:848 - 56; http://dx.doi.org/10.1182/blood-2010-08-301374; PMID: 21030563
   PubMed Web of Science ®Google Scholar
• Romo N, Magri G, Muntasell A, Heredia G, Baía D, Angulo A, et al. Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J Leukoc Biol 2011; 90:717 - 26; http://dx.doi.org/10.1189/jlb.0311171; PMID: 21742939
   PubMed Web of Science ®Google Scholar
• Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999; 180:702 - 7; http://dx.doi.org/10.1086/314939; PMID: 10438357
   PubMed Web of Science ®Google Scholar
• Naniche D, Oldstone MB. Generalized immunosuppression: how viruses undermine the immune response. Cell Mol Life Sci 2000; 57:1399 - 407; http://dx.doi.org/10.1007/PL00000625; PMID: 11078019
   PubMed Web of Science ®Google Scholar
• Carney WP, Rubin RH, Hoffman RA, Hansen WP, Healey K, Hirsch MS. Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 1981; 126:2114 - 6; PMID: 6262407
   PubMed Web of Science ®Google Scholar
• Carney WP, Hirsch MS. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J Infect Dis 1981; 144:47 - 54; http://dx.doi.org/10.1093/infdis/144.1.47; PMID: 6267142
   PubMed Web of Science ®Google Scholar
• Varani S, Rossini G, Mastroianni A, Tammik C, Frascaroli G, Landini MP, et al. High TNF-alpha and IL-8 levels predict low blood dendritic cell counts in primary cytomegalovirus infection. J Clin Virol 2012; 53:360 - 3; http://dx.doi.org/10.1016/j.jcv.2011.12.028; PMID: 22257833
   PubMed Web of Science ®Google Scholar
• Kunitani H, Shimizu Y, Murata H, Higuchi K, Watanabe A. Phenotypic analysis of circulating and intrahepatic dendritic cell subsets in patients with chronic liver diseases. J Hepatol 2002; 36:734 - 41; http://dx.doi.org/10.1016/S0168-8278(02)00062-4; PMID: 12044522
   PubMed Web of Science ®Google Scholar
• Dillon SM, Robertson KB, Pan SC, Mawhinney S, Meditz AL, Folkvord JM, et al. Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection. J Acquir Immune Defic Syndr 2008; 48:1 - 12; http://dx.doi.org/10.1097/QAI.0b013e3181664b60; PMID: 18300699
   PubMed Web of Science ®Google Scholar
• Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998; 28:2760 - 9; http://dx.doi.org/10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; PMID: 9754563
   PubMed Web of Science ®Google Scholar
• Duperray A, Mantovani A, Introna M, Dejana E. Endothelial cell regulation of leukocyte infiltration in inflammatory tissues. Mediators Inflamm 1995; 4:322 - 30; http://dx.doi.org/10.1155/S0962935195000524; PMID: 18475659
   PubMed Web of Science ®Google Scholar
• Frascaroli G, Varani S, Mastroianni A, Britton S, Gibellini D, Rossini G, et al. Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. J Leukoc Biol 2006; 79:932 - 40; http://dx.doi.org/10.1189/jlb.0905499; PMID: 16501053
   PubMed Web of Science ®Google Scholar
• Toro AI, Ossa J. PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?. Res Virol 1996; 147:233 - 8; http://dx.doi.org/10.1016/0923-2516(96)89654-3; PMID: 8837231
   PubMedGoogle Scholar
• Heininger A, Jahn G, Engel C, Notheisen T, Unertl K, Hamprecht K. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med 2001; 29:541 - 7; http://dx.doi.org/10.1097/00003246-200103000-00012; PMID: 11373417
   PubMed Web of Science ®Google Scholar
• Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300:413 - 22; http://dx.doi.org/10.1001/jama.300.4.413; PMID: 18647984
   PubMed Web of Science ®Google Scholar
• Cook CH, Trgovcich J. Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antiviral Res 2011; 90:151 - 9; http://dx.doi.org/10.1016/j.antiviral.2011.03.179; PMID: 21439328
   PubMed Web of Science ®Google Scholar
• Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol 2008; 14:4849 - 60; http://dx.doi.org/10.3748/wjg.14.4849; PMID: 18756591
   PubMed Web of Science ®Google Scholar
• Nichols WG, Corey L, Gooley T, Davis C, Boeckh M. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185:273 - 82; http://dx.doi.org/10.1086/338624; PMID: 11807708
   PubMed Web of Science ®Google Scholar
• Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338:1741 - 51; http://dx.doi.org/10.1056/NEJM199806113382407; PMID: 9624195
   PubMed Web of Science ®Google Scholar
• Sun Q, Hall EC, Huang Y, Chen P, Dibadj K, Murawski M, et al. Pre-transplant myeloid dendritic cell deficiency associated with cytomegalovirus infection and death after kidney transplantation. Transpl Infect Dis 2012; http://dx.doi.org/10.1111/j.1399-3062.2012.00750.x; PMID: 22672201
   PubMed Web of Science ®Google Scholar
• Varani S, Frascaroli G, Gibellini D, Potena L, Lazzarotto T, Lemoli RM, et al. Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. Transplantation 2005; 79:219 - 27; http://dx.doi.org/10.1097/01.TP.0000147359.63158.29; PMID: 15665771
   PubMed Web of Science ®Google Scholar
• Mezger M, Steffens M, Semmler C, Arlt EM, Zimmer M, Kristjanson GI, et al. Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation. Clin Microbiol Infect 2008; 14:228 - 34; http://dx.doi.org/10.1111/j.1469-0691.2007.01902.x; PMID: 18076668
   PubMed Web of Science ®Google Scholar
• Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, et al. Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant 2007; 21:149 - 58; http://dx.doi.org/10.1111/j.1399-0012.2006.00618.x; PMID: 17425738
   PubMed Web of Science ®Google Scholar
• Dzabic M, Rahbar A, Yaiw KC, Naghibi M, Religa P, Fellström B, et al. Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. Clin Infect Dis 2011; 53:969 - 76; http://dx.doi.org/10.1093/cid/cir619; PMID: 21960711
   PubMed Web of Science ®Google Scholar
• Varani S, Landini MP. Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae 2011; 2:6; http://dx.doi.org/10.1186/2042-4280-2-6; PMID: 21473750
   PubMedGoogle Scholar
• Soderberg C, Sumitran-Karuppan S, Ljungman P, Moller E. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation 1996; 61:594 - 600; http://dx.doi.org/10.1097/00007890-199602270-00014; PMID: 8610387
   PubMed Web of Science ®Google Scholar
• Rahbar A, Boström L, Söderberg-Naucler C. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn’s disease. J Autoimmun 2006; 26:155 - 64; http://dx.doi.org/10.1016/j.jaut.2006.02.003; PMID: 16584867
   PubMed Web of Science ®Google Scholar
• Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003; 19:225 - 34; http://dx.doi.org/10.1016/S1074-7613(03)00208-5; PMID: 12932356
   PubMed Web of Science ®Google Scholar
• Carvalho A, Cunha C, Carotti A, Aloisi T, Guarrera O, Di Ianni M, et al. Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. Exp Hematol 2009; 37:1022 - 9; http://dx.doi.org/10.1016/j.exphem.2009.06.004; PMID: 19539691
   PubMed Web of Science ®Google Scholar
• Nahum A, Dadi H, Bates A, Roifman CM. The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity. J Allergy Clin Immunol 2011; 127:528 - 31; http://dx.doi.org/10.1016/j.jaci.2010.09.031; PMID: 21093032
   PubMed Web of Science ®Google Scholar
• Varani S, Mastroianni A, Frascaroli G, Tammik C, Rahbar A, Christensson M, et al. Generalized Wegener’s granulomatosis in an immunocompetent adult after cytomegalovirus mononucleosis and bacterial urinary tract infection. Arthritis Rheum 2009; 60:1558 - 62; http://dx.doi.org/10.1002/art.24487; PMID: 19404959
   PubMed Web of Science ®Google Scholar
• Hsieh AH, Jhou YJ, Liang CT, Chang M, Wang SL. Fragment of tegument protein pp65 of human cytomegalovirus induces autoantibodies in BALB/c mice. Arthritis Res Ther 2011; 13:R162; http://dx.doi.org/10.1186/ar3481; PMID: 21989080
   PubMedGoogle Scholar
• Chang M, Pan MR, Chen DY, Lan JL. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp Immunol 2006; 143:167 - 79; http://dx.doi.org/10.1111/j.1365-2249.2005.02974.x; PMID: 16367948
   PubMed Web of Science ®Google Scholar
• Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 2007; 13:543 - 51; http://dx.doi.org/10.1038/nm1590; PMID: 17479100
   PubMed Web of Science ®Google Scholar
• Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci USA 2009; 106:12061 - 6; http://dx.doi.org/10.1073/pnas.0905441106; PMID: 19574451
   PubMed Web of Science ®Google Scholar
• Xu X, Bergman P, Willows T, Tammik C, Sund M, Hökfelt T, et al. CMV-associated encephalitis and antineuronal autoantibodies - a case report. BMC Neurol 2012; 12:87; http://dx.doi.org/10.1186/1471-2377-12-87; PMID: 22947340
   PubMed Web of Science ®Google Scholar
• Zucchini N, Bessou G, Traub S, Robbins SH, Uematsu S, Akira S, et al. Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J Immunol 2008; 180:5799 - 803; PMID: 18424698
   PubMed Web of Science ®Google Scholar
• Rahbar A, Boström L, Lagerstedt U, Magnusson I, Söderberg-Naucler C, Sundqvist VA. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 2003; 9:154 - 61; http://dx.doi.org/10.1097/00054725-200305000-00002; PMID: 12792220
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Metzke D, Schmitz J, Scheffold A, Sturm A, Wiedenmann B, et al. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005; 54:228 - 36; http://dx.doi.org/10.1136/gut.2004.040360; PMID: 15647187
   PubMed Web of Science ®Google Scholar
• Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression. J Clin Invest 1994; 93:474 - 8; http://dx.doi.org/10.1172/JCI116995; PMID: 8113386
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Steinman RM. Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cells. J Dermatol Sci 2009; 54:69 - 75; http://dx.doi.org/10.1016/j.jdermsci.2009.02.001; PMID: 19286352
   PubMed Web of Science ®Google Scholar
• Ngoma AM, Ikeda K, Hashimoto Y, Mochizuki K, Takahashi H, Sano H, et al. Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation. Int J Hematol 2012; 95:86 - 94; http://dx.doi.org/10.1007/s12185-011-0976-7; PMID: 22160825
   PubMed Web of Science ®Google Scholar
• Pastore D, Delia M, Mestice A, Perrone T, Carluccio P, Gaudio F, et al. Recovery of CMV-specific CD8+ T cells and Tregs after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:550 - 7; http://dx.doi.org/10.1016/j.bbmt.2010.04.011; PMID: 20457268
   PubMed Web of Science ®Google Scholar
• Nguyen VH, Shashidhar S, Chang DS, Ho L, Kambham N, Bachmann M, et al. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood 2008; 111:945 - 53; http://dx.doi.org/10.1182/blood-2007-07-103895; PMID: 17916743
   PubMed Web of Science ®Google Scholar
• Bruinsma M, Wils EJ, Löwenberg B, Cornelissen JJ, Braakman E. The impact of CD4+Foxp3+ Treg on immunity to murine cytomegalovirus after bone marrow transplantation depends on the peripheral or thymic source of T cell regeneration. Transpl Immunol 2010; 24:9 - 16; http://dx.doi.org/10.1016/j.trim.2010.08.003; PMID: 20801217
   PubMed Web of Science ®Google Scholar
• Li YN, Liu XL, Huang F, Zhou H, Huang YJ, Fang F. CD4+CD25+ regulatory T cells suppress the immune responses of mouse embryo fibroblasts to murine cytomegalovirus infection. Immunol Lett 2010; 131:131 - 8; http://dx.doi.org/10.1016/j.imlet.2010.03.011; PMID: 20381532
   PubMed Web of Science ®Google Scholar
• Streblow DN, Orloff SL, Nelson JA. Do pathogens accelerate atherosclerosis?. J Nutr 2001; 131:2798S - 804S; PMID: 11584110
   PubMedGoogle Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868 - 74; http://dx.doi.org/10.1038/nature01323; PMID: 12490960
   PubMed Web of Science ®Google Scholar
• Bobryshev YV, Lord RS, Pärsson H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc Surg 1998; 6:240 - 9; http://dx.doi.org/10.1016/S0967-2109(97)00168-3; PMID: 9705095
   PubMedGoogle Scholar
• Millonig G, Malcom GT, Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002; 160:441 - 8; http://dx.doi.org/10.1016/S0021-9150(01)00596-2; PMID: 11849669
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004; 176:101 - 10; http://dx.doi.org/10.1016/j.atherosclerosis.2004.04.027; PMID: 15306181
   PubMed Web of Science ®Google Scholar
• Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 2008; 118:1276 - 84; http://dx.doi.org/10.1161/CIRCULATIONAHA.108.789172; PMID: 18765390
   PubMed Web of Science ®Google Scholar
• Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 2006; 114:2482 - 9; http://dx.doi.org/10.1161/CIRCULATIONAHA.106.642801; PMID: 17116765
   PubMed Web of Science ®Google Scholar
• Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1994; 42:170 - 4; http://dx.doi.org/10.1002/jmv.1890420213; PMID: 8158112
   PubMed Web of Science ®Google Scholar
• Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; 2:644 - 7; http://dx.doi.org/10.1016/S0140-6736(83)92529-1; PMID: 6136795
   PubMed Web of Science ®Google Scholar
• Gredmark S, Jonasson L, Van Gosliga D, Ernerudh J, Söderberg-Nauclér C. Active cytomegalovirus replication in patients with coronary disease. Scand Cardiovasc J 2007; 41:230 - 4; http://dx.doi.org/10.1080/14017430701383755; PMID: 17680510
   PubMed Web of Science ®Google Scholar
• Roberts ET, Haan MN, Dowd JB, Aiello AE. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol 2010; 172:363 - 71; http://dx.doi.org/10.1093/aje/kwq177; PMID: 20660122
   PubMed Web of Science ®Google Scholar
• Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011; 6:e16103; http://dx.doi.org/10.1371/journal.pone.0016103; PMID: 21379581
   PubMed Web of Science ®Google Scholar
• Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, et al. Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology 1995; 208:197 - 206; http://dx.doi.org/10.1006/viro.1995.1143; PMID: 11831701
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Remmerswaal EB, Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173:1834 - 41; PMID: 15265915
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000; 101:2883 - 8; http://dx.doi.org/10.1161/01.CIR.101.25.2883; PMID: 10869258
   PubMed Web of Science ®Google Scholar
• Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, et al. Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol 1999; 90:213 - 9; http://dx.doi.org/10.1006/clim.1998.4638; PMID: 10080833
   PubMed Web of Science ®Google Scholar
• Hazzan M, Labalette M, Noel C, Lelievre G, Dessaint JP. Recall response to cytomegalovirus in allograft recipients: mobilization of CD57+, CD28+ cells before expansion of CD57+, CD28- cells within the CD8+ T lymphocyte compartment. Transplantation 1997; 63:693 - 8; http://dx.doi.org/10.1097/00007890-199703150-00014; PMID: 9075840
   PubMed Web of Science ®Google Scholar
• Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, et al. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol 2009; 183:4792 - 9; http://dx.doi.org/10.4049/jimmunol.0803688; PMID: 19752224
   PubMed Web of Science ®Google Scholar
• Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A. Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells. Virology 2010; 398:158 - 67; http://dx.doi.org/10.1016/j.virol.2009.11.038; PMID: 20034645
   PubMed Web of Science ®Google Scholar
• Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379 - 85; http://dx.doi.org/10.1038/nm0402-379; PMID: 11927944
   PubMed Web of Science ®Google Scholar
• Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 2005; 175:8218 - 25; PMID: 16339561
   PubMed Web of Science ®Google Scholar